首页>外文期刊>医学、药学、卫生>临床医学>Advances in cell and gene therapy.

Advances in cell and gene therapy.

中文名称：细胞和基因治疗的进步。

ISSN：2573-8461
出版周期：Four issues a year

发文量：67

期刊论文

热门论文

年度选择

更多>>

全选（0）

1.Cytokine syndromes associated with hematopoietic cellular therapy

机译：与造血细胞疗法相关的细胞因子综合征
- 作者：Thomas R. Spitzer
- 期刊名称：《Advances in cell and gene therapy.》 | 2021年第1期
2.Advances & future prospects in newly diagnosed multiple myeloma patients

机译：新诊断的多个骨髓瘤患者的进步和未来前景
- 作者：Issam Hamadeh;Shebli Atrash;Ashley Matusz FisherMaham A. KhanJordan Diana RobinsonPaul BarrySaad Z. Usmani
- 期刊名称：《Advances in cell and gene therapy.》 | 2021年第1期
3.Approaching the first relapse after autologous transplant in multiple myeloma

机译：在多发性骨髓瘤中自体移植后接近第一次复发
- 作者：Shebli Atrash;Issam Hamadeh;Ashley Matusz-FisherAmi NdiayeManisha BhutaniPeter M. VoorheesPaul BarrySaad Z. Usmani
- 期刊名称：《Advances in cell and gene therapy.》 | 2021年第1期
4.CD276 as a novel CAR NK-92 therapeutic target for neuroblastoma

机译：CD276是神经母细胞瘤的新型CAR NK-92治疗靶标
- 作者：Stefan Grote;Kenneth Chun-Ho Chan;Caroline BadenHans B?smüllerMihály SulyokLeonie FrauenfeldMartin EbingerRupert HgretingerSabine Schleicher
- 期刊名称：《Advances in cell and gene therapy.》 | 2021年第1期
- Neuroblastoma;
- Antigen Receptors;
- CD276 gene;
5.Combining the disease risk index and hematopoietic cell transplant co-morbidity index provides a comprehensive prognostic model for CD34~+-selected allogeneic transplantation

机译：结合疾病风险指数和造血细胞移植合并症指数为CD34〜+选择的同种异体移植提供了全面的预后模型
- 作者：Christina Cho;Patrick Hilden;Scott T. AvecillaJuliet N. BarkerHugo Castro-MalaspinaSergio A. GiraltBoglarka GyurkoczaAnn A. JakubowskiMolly A. MaloyRichard J. OReillyEsperanza B. PapadopoulosJonathan U. PeledDoris M. PonceBrian ShafferRoni TamariMarcel R. M. van den BrinkJames W. YoungPere BarbaMiguel-Angel Perales
- 期刊名称：《Advances in cell and gene therapy.》 | 2021年第1期
6.Engineering oncolytic vaccinia virus to redirect macrophages to tumor cells

机译：工程性溶瘤疫苗病毒将巨噬细胞重定向到肿瘤细胞
- 作者：Felicia Cao;Phuong Nguyen;Bangxing HongChristopher DeRenzoNino C. RainussoTania Rodriguez CruzMeng-Fen WuHao LiuXiao-Tong SongMasataka SuzukiLisa L. WangJason T. YusteinStephen Gottschalk
- 期刊名称：《Advances in cell and gene therapy.》 | 2021年第2期
7.Leveraging minimal residual disease to reassess autologous hematopoietic cell transplantation in multiple myeloma

机译：利用最小残留疾病，以重新评估多发性骨髓瘤的自体造血细胞移植
- 作者：Susan Bal;Luciano J. Costa
- 期刊名称：《Advances in cell and gene therapy.》 | 2021年第2期
8.An in silico analysis of effective siRNAs against COVID-19 by targeting the leader sequence of SARS-CoV-2

机译：通过靶向SARS-COV-2的领导者序列对COVID-19的有效siRNA的计算机分析
- 作者：An Kumar Pey;Shalja Verma
- 期刊名称：《Advances in cell and gene therapy.》 | 2021年第2期
- SARS coronavirus;
- RNAi Therapeutics;
- Small Interfering RNAStrandsLeader sequencemolecular docking;
9.Myeloablative haploidentical t-cell replete hematopoietic cell transplantation with post-transplant cyclophosphamide in high-risk hematological malignancies: Bending the learning curve in a middle-income setting

机译：高风险血液学恶性肿瘤中移植后环磷酰胺的骨髓性单倍体T细胞造血细胞移植：在中等收入设置中弯曲学习曲线
- 作者：Sanket P. Shah;Vivek S. Radhakrishnan;Ganesh S. JaishetwarReghu K. SukumaranJeevan KumarSaurabh J. BhaveMita RoychowdhurySayak ChaudhuriDeepak K. MishraReena NairShekhar KrishnanMammen Chy
- 期刊名称：《Advances in cell and gene therapy.》 | 2021年第2期
10.Molecular aberrations in myelodysplastic syndromes

机译：骨髓增生综合征的分子像差
- 作者：Nikesh N.Shah;Rami S. Komrokji
- 期刊名称：《Advances in cell and gene therapy.》 | 2021年第3期
11.Immunological tumor heterogeneity and diagnostic profiling for advanced and immune therapies

机译：晚期和免疫疗法的免疫学肿瘤异质性和诊断分析
- 作者：Ralf Huss;Christoph Schmid;Mael ManesseJeppe ThagaardBruno Maerkl
- 期刊名称：《Advances in cell and gene therapy.》 | 2021年第3期
12.Inhospital morbidity and mortality among acute myeloid leukemia patients admitted for hematopoietic stem cell transplantation between 2002-2017

机译：急性髓细胞性白血病患者的院子里发病率和死亡率在2002 - 2017年之间接受造血干细胞移植。
- 作者：Saqib Abbasi;Joseph Bennett;Osama DiabGhulam Rehman MohyuddinAnurag Singh
- 期刊名称：《Advances in cell and gene therapy.》 | 2021年第3期
13.Prolonged neurotoxicity in a lymphoma patient after CD19-directed CAR T-cell therapy: A case report and brief review of the literature

机译：CD19导向的CAR T细胞疗法后，淋巴瘤患者的神经毒性长时间：病例报告和文献简要审查
- 作者：Uri Greenbaum;Jeremy L. Ramdial;Ama OlsonYago NietoPaolo StratiSairah AhmedSattva S. NeelapuSudhakar TummalaLinda ChiElizabeth J. ShpallPartow Kebriaei
- 期刊名称：《Advances in cell and gene therapy.》 | 2021年第3期
14.Identification of homologous human miRNAs as antivirals towards COVID-19 genome

机译：鉴定同源人miRNA作为抗病毒症，涉及19个基因组
- 作者：Jitender Singh;Ashvinder Raina;Namrata SangwanArushi ChauhanKrishan L KhujaPramod K. Avti
- 期刊名称：《Advances in cell and gene therapy.》 | 2021年第4期
- Antiviral Agents;
- MicroRNAs;
- Gibbs free energyOntologyhybridisationBase Pairing;
15.Advances in relapsed/refractory follicular lymphoma therapeutics

机译：复发/难治性卵泡淋巴瘤疗法的进展
- 作者：Kharchenko Evgeniya V.;Sweetenham John W.
- 期刊名称：《Advances in cell and gene therapy.》 | 2020年第1期
16.Issue Information

机译：问题信息
- 期刊名称：《Advances in cell and gene therapy.》 | 2020年第1期
17.Cancer‐associated thrombosis: Where do we stand?

机译：与癌症相关的血栓形成：我们在哪里？
- 作者：Al‐Samkari Hanny;Song Andrew B.;Connors Jean M.
- 期刊名称：《Advances in cell and gene therapy.》 | 2020年第1期
18.Future prospects of chimeric antigen receptor T‐cell therapy for multiple myeloma

机译：多发性骨髓瘤的嵌合抗原受体T细胞疗法的未来前景
- 作者：Fernandez de Larrea Carlos;Mailankody Sham;Landgren OlaSmith Eric L.
- 期刊名称：《Advances in cell and gene therapy.》 | 2020年第1期
- Cell Therapy;
- Multiple Myeloma;
- immunotherapyAntigen Receptors;
19.Minimal residual disease in multiple myeloma 2019

机译：多发性骨髓瘤2019年的残留最小残留疾病
- 作者：Kunacheewa Chutima;Lin Pei;Manasanch Elisabet E.
- 期刊名称：《Advances in cell and gene therapy.》 | 2020年第1期
20.Important aspects of T‐cell collection by apheresis for manufacturing chimeric antigen receptor T cells

机译：在生产嵌合抗原受体T细胞中，通过格式收集T细胞收集的重要方面
- 作者：Paroder Monika;Le Nguyet;Pham Huy P.Thibodeaux Suzanne R.
- 期刊名称：《Advances in cell and gene therapy.》 | 2020年第1期
21.Update on the classification of myeloid neoplasms: The 2016 revised World Health Organization classification of hematopoietic and lymphoid neoplasms

机译：髓样肿瘤分类的最新信息：2016年修订的造血和淋巴肿瘤的世界卫生组织分类
- 作者：Sangiorgio Valentina;Orazi Attilio
- 期刊名称：《Advances in cell and gene therapy.》 | 2020年第2期
22.Selecting patients with primary myelofibrosis for stem cell transplant using clinical, mutational, and transplant‐specific profiles

机译：使用临床，突变和移植特异性特征选择一级骨髓纤维化患者进行干细胞移植的患者
- 作者：Gagelmann Nico;Kr?ger Nicolaus
- 期刊名称：《Advances in cell and gene therapy.》 | 2020年第2期
23.Recently approved molecularly targeted therapies in AML

机译：最近批准的AML分子靶向疗法
- 作者：Papadantonakis Nikolaos;Erba Harry P.
- 期刊名称：《Advances in cell and gene therapy.》 | 2020年第2期
24.Issue Information

机译：问题信息
- 期刊名称：《Advances in cell and gene therapy.》 | 2020年第2期
25.Prevention of relapse after allogeneic stem cell transplantation in acute myeloid leukemia: Updates and challenges

机译：急性髓样白血病的同种异体干细胞移植后预防复发：更新和挑战
- 作者：Thekkudan Shinto F.;Lima Marcos;Metheny Leland
- 期刊名称：《Advances in cell and gene therapy.》 | 2020年第2期
26.RNA ImmunoGenic Assay: Simple method for detecting immunogenicity of in vitro transcribed mRNA

机译：RNA免疫原性测定：检测体外转录mRNA免疫原性的简单方法
- 作者：Haque AKM Ashiqul;Weinmann Petra;Biswas SumitHandgretinger RupertMezger MarkusKormann Michael S. D.Antony Justin S.
- 期刊名称：《Advances in cell and gene therapy.》 | 2020年第2期
- Blood;
- Cytokines;
- immunogenicityImmune ResponseUridineMessenger RNARNA;
27.Prospective platelet auditing: Resident compliance and the cost of training

机译：潜在的血小板审核：居民合规性和培训费用
- 作者：Sarah Vossoughi;David Romoff;Joseph Schwartz
- 期刊名称：《Advances in cell and gene therapy.》 | 2020年第3期
28.Toward 'off-the-shelf' allogeneic CAR T cells

机译：走向“现成”同种异体车T细胞
- 作者：Blake T. Aftab;Barbra Sasu;Janani KrishnamurthyEric GschwengVincent AlcazerStéphane Depil
- 期刊名称：《Advances in cell and gene therapy.》 | 2020年第3期
- T-Lymphocytes;
- immunotherapy;
- Gene Editingallogenic bone marrow transplantation;
29.TRUCKS, the fourth-generation CAR T cells: Current developments and clinical translation

机译：卡车，第四代汽车T细胞：当前的发展和临床翻译
- 作者：Markus Chmielewski;Hinrich Abken
- 期刊名称：《Advances in cell and gene therapy.》 | 2020年第3期
30.Primary central nervous system lymphoma: Consensus, controversies, and future directions

机译：原发性中枢神经系统淋巴瘤：共识，争议和未来方向
- 作者：Talal Hilal
- 期刊名称：《Advances in cell and gene therapy.》 | 2020年第3期
- primary CNS lymphoma;
- Lymphoma;
- RelapseDisputes;
31.Circulating tumor DNA in lymphomas: Era of precision medicine

机译：淋巴瘤中循环肿瘤DNA：精密医学时代
- 作者：Avyakta Kallam;Jayanth Adusumalli;Kai FuJames O. Armitage
- 期刊名称：《Advances in cell and gene therapy.》 | 2020年第3期
32.COVID-19 & allogeneic transplant: Activity and preventive measures for best outcomes in China

机译：Covid-19和同种异体移植：中国最佳结果的活动和预防措施
- 作者：Zheng-Li Xu;Xiao-Jun Huang
- 期刊名称：《Advances in cell and gene therapy.》 | 2020年第4期
33.Expert perspective: Highlights on myeloma cell therapy from the American Society of Hematology Annual Meeting 2019

机译：专家观点：2019年美国血液学年度会议的骨髓瘤细胞疗法的亮点
- 作者：Chutima Kunacheewa;Elisabet E. Manasanch
- 期刊名称：《Advances in cell and gene therapy.》 | 2020年第4期
34.Perspective: Cell therapy, SARS-CoV-2, COVID-19, and James Lind

机译：透视图：细胞疗法，SARS-COV-2，COVID-19和James Lind
- 作者：Robert P. Gale
- 期刊名称：《Advances in cell and gene therapy.》 | 2020年第4期
35.When to consider allogeneic transplant for chronic myeloid leukemia

机译：何时考虑慢性髓样白血病的同种异体移植
- 作者：Daniel Egan;Jerald Radich
- 期刊名称：《Advances in cell and gene therapy.》 | 2020年第4期
36.Use of thrombopoietin receptor agonists after hematopoietic progenitor cell transplantation

机译：造血祖细胞移植后使用血小板素受体激动剂
- 作者：Sara Singer;Basem M. William
- 期刊名称：《Advances in cell and gene therapy.》 | 2020年第4期
37.Rapid production of clinical-grade SARS-CoV-2 specific T cells

机译：快速生产临床级SARS-COV-2特异性T细胞
- 作者：Wing Leung;TeckGuanSoh;Yeh Ching LinnJenny Guek-Hong LowJiashen LohMarieta Chan
- 期刊名称：《Advances in cell and gene therapy.》 | 2020年第4期
38.Biomarker profiling of steroid-resistant chronic GvHD patients undergoing extracorporeal photopheresis demonstrates high ST2 levels at treatment onset and decline during therapy

机译：类固醇慢性GVHD患者的生物标志物分析在治疗时表现出高的ST2水平，在治疗期间降低了ST2水平
- 作者：Neil Dunavin;Mitchell W. Braun;Meizhang LiAndrew K. GodwinSunil AbhyankarThomas M. Yankee
- 期刊名称：《Advances in cell and gene therapy.》 | 2019年第1期
39.Do hypomethylating agents prevent relapse after Allo-HCT?

机译：低甲基化剂是否可以防止Allo-HCT后复发？
- 作者：Thomas Schroeder;Christina Rautenberg;Rainer HaasUlrich GermingGuido Kobbe
- 期刊名称：《Advances in cell and gene therapy.》 | 2019年第1期
40.Advances in ex vivo T cell depletion - where do we stand?

机译：离体T细胞耗竭的进展 - 我们站在哪里？
- 作者：Adam R. Bryant;Miguel-Angel Perales
- 期刊名称：《Advances in cell and gene therapy.》 | 2019年第1期
41.From bench to bedside: Exploiting memory NK cell responses to leukemia

机译：从长凳到床头：利用记忆NK细胞对白血病的反应
- 作者：Marina Schmidt;Maya C.Andre
- 期刊名称：《Advances in cell and gene therapy.》 | 2019年第1期
- Leukemia;
- Natural Killer Cells;
- CytomegalovirusCytokinesLongevityAdoptive Cell Transfer;
42.Targeting reservoirs of HIV replication in lymphoid follicles with cellular therapies to cure HIV

机译：靶向用细胞疗法治愈HIV的淋巴卵泡中HIV复制的储层
- 作者：Pamela J. Skinner
- 期刊名称：《Advances in cell and gene therapy.》 | 2019年第1期
43.Meeting report: Advances in minimal residual disease testing in multiple myeloma 2018

机译：会议报告：多发性骨髓瘤2018中最小残留疾病测试的进展
- 作者：Ola Lgren;Even H. Rustad
- 期刊名称：《Advances in cell and gene therapy.》 | 2019年第1期
- Minimal Residual Disease;
- Multiple Myeloma;
- Drug Approval;
44.Advances in transplantation and gene therapy in transfusion-dependent beta-thalassemia

机译：输血依赖性β-甲性贫血的移植和基因治疗的进展
- 作者：Emanuele Angelucci;Syed A. Abutalib
- 期刊名称：《Advances in cell and gene therapy.》 | 2019年第1期
45.List of Reviewers - 2018 - Advances in Cell and Gene Therapy

机译：审稿人名单 - 2018年 - 细胞和基因疗法的进展
- 期刊名称：《Advances in cell and gene therapy.》 | 2019年第2期
- Genetic Therapy;
- Peer Review;
- journals;
46.The therapeutic role of natural killer cells in multiple myeloma

机译：天然杀伤细胞在多发性骨髓瘤中的治疗作用
- 作者：Ghulam Rehman Mohyuddin;Muzaffar H. Qazilbash
- 期刊名称：《Advances in cell and gene therapy.》 | 2019年第2期
47.Advances in chronic myelomonocytic leukemia and future prospects: Lessons learned from precision genomics

机译：慢性脊髓细胞性白血病和未来前景的进步：从精确基因组学中学到的经验教训
- 作者：Abhishek A. Mangaonkar;Mrinal M. Patnaik
- 期刊名称：《Advances in cell and gene therapy.》 | 2019年第2期
48.High-dose chemotherapy and autologous transplantation for testicular germ cell tumors

机译：睾丸生殖细胞肿瘤的高剂量化疗和自体移植
- 作者：Naimisha Marneni;Navneet S. Majhail;Timothy D. GilliganMoshe C. Ornstein
- 期刊名称：《Advances in cell and gene therapy.》 | 2019年第2期
49.Allogeneic CD27-depleted cells in adoptive cell therapy

机译：收养细胞疗法中的同种异体CD27细胞
- 作者：Aimee C. Talleur;Jean-Yves Metais;Ying LiRobert E. ThromHeather TillmanBarbara RooneyArdiana MoustakiWing Leung
- 期刊名称：《Advances in cell and gene therapy.》 | 2019年第2期
50.Viral infections after allogeneic hematopoietic stem cell transplant

机译：同种异体造血干细胞移植后的病毒感染
- 作者：Alankrita Taneja;Joseph H. Chewning;Ayman Saad
- 期刊名称：《Advances in cell and gene therapy.》 | 2019年第2期
51.Donor selection for haploidentical hematopoietic cell transplantation- practice guidance

机译：单倍症造血细胞移植的供体选择 - 实践指导
- 作者：Yu-Qian Sun;Ying-Jun Chang;Xiao-Jun Huang
- 期刊名称：《Advances in cell and gene therapy.》 | 2019年第2期
52.The role of autologous stem cell transplantation in diffuse large B-cell lymphoma

机译：自体干细胞移植在扩散的大B细胞淋巴瘤中的作用
- 作者：Liana Nikolaenko;Alex F. Herrera
- 期刊名称：《Advances in cell and gene therapy.》 | 2019年第2期
53.Advances in BCR/ABL positive ALL

机译：BCR/ABL阳性的进步
- 作者：Netanel A. Horowitz;Jacob M. Rowe
- 期刊名称：《Advances in cell and gene therapy.》 | 2019年第3期
54.Updates and rationale of clinical trials in multiple myeloma

机译：多发性骨髓瘤的临床试验的更新和理由
- 作者：Andrew R. Branagan;Matthew Lei;Carolyn TraceyNoopur S. Raje
- 期刊名称：《Advances in cell and gene therapy.》 | 2019年第3期
- mechanism of action;
- Multiple Myeloma;
- immunotherapynew combinationClinical Trial;
55.Update on Lymphoma classification: The 2016 revised World Health Organization Classification of Hematopoietic and Lymphoid Neoplasms

机译：淋巴瘤分类的最新信息：2016年修订的造血和淋巴肿瘤的世界卫生组织分类
- 作者：Ali Sakhdari;L.Jeffrey Medeiros
- 期刊名称：《Advances in cell and gene therapy.》 | 2019年第3期
56.Does an increased probability of graft-vs-host disease improve the survival of patients with adult T-cell leukemia-lymphoma? A simulation analysis using a Markov model

机译：GRAFT-VS-HOST疾病的可能性增加是否可以改善成人T细胞白血病 - 淋巴瘤患者的存活？使用马尔可夫模型的仿真分析
- 作者：Shigeo Fuji;Saiko Kurosawa;Yoshihiro InamotoNobuaki NakanoYasuhiko MiyazakiKaname MiyashitaMichihiro HidakaTetsuya EtoNaoyuki UchidaAsahi ItoYasushi SawayamaToshihiro MiyamotoJunji SuzumiyaAtae UtsunomiyaJunya KaYoshiko AtsutaTakahiro FukudaKoji Katoon behalf of Adult T-cell Leukemia-Working Group of Japan Society of Hematopoietic Cell
- 期刊名称：《Advances in cell and gene therapy.》 | 2019年第3期
57.Advances in the treatment of chronic graft-versus-host disease

机译：治疗慢性移植抗宿主病的进展
- 作者：Eric D. Johnson;Daniel R. Couriel
- 期刊名称：《Advances in cell and gene therapy.》 | 2019年第3期
58.CAR-T cell therapy for non-Hodgkin lymphomas: A new treatment paradigm

机译：非霍奇金淋巴瘤的CAR-T细胞疗法：一种新的治疗范式
- 作者：LaQuisa Hill;Premal Lulla;Helen E Heslop
- 期刊名称：《Advances in cell and gene therapy.》 | 2019年第3期
59.Advances in CMV infection prevention and treatment after allo-HSCT

机译：Allo-HSCT后CMV感染预防和治疗的进展
- 作者：Corrado Girmenia
- 期刊名称：《Advances in cell and gene therapy.》 | 2019年第3期
60.Advances in drug-based therapies in chronic lymphocytic leukemia and future prospects

机译：慢性淋巴细胞性白血病和未来前景的基于药物的疗法的进步
- 作者：Jennifer L. Crombie;Jennifer R. Brown
- 期刊名称：《Advances in cell and gene therapy.》 | 2019年第3期
- B-Cell Chronic Lymphocytic Leukemia;
- Molecular Targeted Therapy;
61.Case report: Impact of BITE on CAR-T cell expansion

机译：病例报告：咬合对CAR-T细胞扩展的影响
- 作者：Haneen Shalabi;Ashley Koegel;Anusha PonduriHaiying QinDalia SalemMaryalice Stetler-StevensonConstance YuanBonnie YatesCindy DelbrookMignon LohTerry J. FryNirali N. Shah
- 期刊名称：《Advances in cell and gene therapy.》 | 2019年第3期
- Leukemia;
- Bites;
- immunotherapyT-Lymphocytescell expansionCase ReportsMT-103 antibody;
62.T-cell acute lymphoblastic leukemia: Current approach and future directions

机译：T细胞急性淋巴细胞白血病：当前方法和未来方向
- 作者：Marlise R. Luskin;Daniel J. DeAngelo
- 期刊名称：《Advances in cell and gene therapy.》 | 2019年第4期
63.Philadelphia chromosome-like acute lymphocytic leukemia: Perspectives on diagnosis

机译：费城染色体样急性淋巴细胞白血病：诊断观点
- 作者：Kevin Prescott;Wendy Stock
- 期刊名称：《Advances in cell and gene therapy.》 | 2019年第4期
- Pennsylvania;
- Leukemia;
- PhiladelphiaPhiladelphia Chromosome;
64.When should transplant physicians think about familial blood cancers?

机译：移植医师何时应该考虑家庭血液癌？
- 作者：Amy M.Trottier;Sarah Bannon;Qaiser BashirHetty E. CarrawayInga HofmannLucy A. Godley
- 期刊名称：《Advances in cell and gene therapy.》 | 2019年第4期
65.Advances in measurable residual disease monitoring for adult acute lymphoblastic leukemia

机译：成人急性淋巴细胞白血病的可测量残留疾病监测的进展
- 作者：Kapil Sankar Meleveedu;Mark Litzow
- 期刊名称：《Advances in cell and gene therapy.》 | 2019年第4期
- Residual Disease;
- Adult Acute Lymphoblastic Leukemia;
- oncologyStem Cell Transplantation;
66.Establishing a standardized system for review and adjudication of chronic graft-vs-host disease data in accordance with the National Institutes Consensus criteria

机译：建立标准化系统，以根据美国国立机构的共识标准审查和裁决慢性移植-VS-host疾病数据
- 作者：Djamilia Dierov;Nicholas Webb;Samira FatmiChamberlain NwanneCristi CiolinoKara MosessoJimmy NievesMiguel-Angel PeralesSusan E. ProckopDoris M. Ponce
- 期刊名称：《Advances in cell and gene therapy.》 | 2019年第4期
67.Characteristics of Sweet's syndrome associated with novel acute myeloid leukemia targeted drugs-Midostaurin and Enasidenib

机译：与新型急性髓细胞性白血病有关的Sweet综合征的特征，靶向药物中库蛋白和依替尼替尼
- 作者：Anahat Kaur;Melissa S. Jacobs;Shahzad Raza
- 期刊名称：《Advances in cell and gene therapy.》 | 2019年第4期
- Molecular Targeted Therapy;
- Sweet Syndrome;
- MidostaurinAcute Myelocytic Leukemias;
68.Azacitidine as salvage therapy for relapsed acute myeloid leukemia/myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantation

机译：Azacitidine as salvage therapy for relapsed acute myeloid leukemia/myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantation
- 作者：Takayuki Ozawa;Shigeo Fuji;Ichiro KawashimaYuki SuekiMasao HagiharaNaoko HaReiko ItoTomoko YamashitaYuji KikuchiAkira OhwadaYasuhiro MatsuuraKota YoshifujiTakashi TanakaYoshihiro InamotoSaiko KurosawaSung-Won KimTakahiro Fukuda
- 期刊名称：《Advances in cell and gene therapy.》 | 2019年第3期
- acute myeloid leukemia;
- allogeneic stem cell transplantation;
- azacitidine;
- myelodysplastic syndrome;
- salvage therapy;

客服邮箱：kefu@zhangqiaokeyan.com

客服微信
服务号